On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion.
about
Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptorThe p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factorThe distribution of SNPs in human gene regulatory regionsCurrent Trends of Renal Impairment in Multiple MyelomaRegulation of serum amyloid A protein expression during the acute-phase responseTacrolimus suppresses tumour necrosis factor-alpha and protects against splanchnic artery occlusion shockRepression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene productTranscriptional potencies of inhaled glucocorticoids.Nerve growth factor activates the RARbeta2 promoter by a Ras-dependent mechanism.The effects of antidepressant treatment on serum cytokines and nutritional status in hemodialysis patients.Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.Regulation of interleukin-6 secretion from breast cancer cells and its clinical implications.Change in markers of bone metabolism with chemotherapy for advanced prostate cancer: interleukin-6 response is a potential early indicator of response to therapy.Glucocorticoids and rheumatoid arthritis: back to the future?Modulation of immune responses in stress by Yoga.Recent advances in asthma.IL-6 and NF-IL6 in acute-phase response and viral infection.Production of interleukin-6 by synovial fibroblasts in rheumatoid arthritis.Combination therapy of long-acting beta2-adrenoceptor agonists and corticosteroids for asthma.Defective inflammatory response in interleukin 6-deficient mice.Ceramide induces interleukin 6 gene expression in human fibroblasts.The mammalian transcriptional repressor RBP (CBF1) regulates interleukin-6 gene expression.Recombination signal sequence binding protein Jkappa is constitutively bound to the NF-kappaB site of the interleukin-6 promoter and acts as a negative regulatory factorRetinoid antagonism of NF-IL6: insight into the mechanism of antiproliferative effects of retinoids in Kaposi's sarcoma.A steroid hormone response unit in the late leader of the noncoding control region of the human polyomavirus BK confers enhanced host cell permissivity.Expression of Retinoic Acid Receptor (RAR) α Protein in the Synovial Membrane from Patients with Osteoarthritis and Rheumatoid ArthritisCerebral small vessel disease: genetic risk assessment for prevention and treatment.Granulocyte-colony stimulating factor concentrations in a patient with plasma cell dyscrasia and clinical features of chronic neutrophilic leukaemia.The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritisRepressor to activator switch by mutations in the first Zn finger of the glucocorticoid receptor: is direct DNA binding necessary?RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation.Expression and function of interleukin-6 in epithelial cells.IL6 gene polymorphisms and susceptibility to colorectal cancer: a meta-analysis and review.Genetics of leprosy reactions: an overview.Separation of transactivation and AP1 antagonism functions of retinoic acid receptor alpha.Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide.Interferon-alpha synergistically enhances induction of interleukin-6 by double stranded RNA in HeLa cells.Retinoic acid receptor-nuclear factor-interleukin 6 antagonism. A novel mechanism of retinoid-dependent inhibition of a keratinocyte hyperproliferative differentiation marker.Nuclear factor interleukin 6 motifs mediate tissue-specific gene transcription in hypoxia.Superantigens and cystic fibrosis: resistance of presenting cells to dexamethasone
P2860
Q24561876-440572EE-BE18-437F-BCED-C64BB349A3EEQ24563111-DB7B8A88-DB8E-4432-95A8-B969AFC1E6DDQ24814028-07250C26-247B-48FC-B6D7-59F785C06872Q26740444-4B3D0B2A-2AF2-4408-B577-90EE5FAC58BCQ28281545-BE04124B-A15A-4E7C-8B4E-7D75B3471F29Q28343410-C1D04525-1AA8-4899-AC30-C93A18E53B97Q28645822-E545BCBD-2228-4BB4-BD87-D1B62413E37EQ31409970-8DEA6E97-B42A-4FF6-9B51-FFC4F6BA9773Q31832133-46D7CB1C-5824-40B9-A58F-77831EE66719Q33631552-20C256D6-694C-4A50-884F-C86DAD75AE1AQ33764990-841A27AB-49F4-4D77-9F62-8AF890C7430CQ34058941-605B1EB0-98E3-4213-B18D-7A55A20CFD6EQ34207923-7692EA5C-869C-40BB-BFB8-C43723754AAAQ34972556-2C0C014D-93F0-4DDA-B1E8-F8901FF6EE7CQ35130750-2EDCF2F1-BB44-4A60-8612-241711185583Q35277314-578E3DC5-E759-4723-B6A5-38702A855B79Q35332588-7BF21FF1-AF58-46E6-A045-F5AABD98C5CDQ35765098-B3C5C69D-C231-43AD-A6AC-AA7465AC51BDQ35987693-E1EC89B9-526E-4AF4-9604-E4EFBE036D7EQ36363772-69C6B455-16A2-49F5-A14E-9FC9662B9183Q36365289-24531C47-4A61-46FA-800E-5191F5D0D00FQ36564525-BF36A128-BFC6-4481-97CA-8ED4DE3A7EF7Q36569110-1AB8588F-7434-4F9D-BCB6-EDE51F31A4E2Q36569469-04C1A43E-E541-4584-9916-B15A5AB0AB02Q36632077-996BE680-83B1-4176-943C-CE8A57D16F2CQ36735235-CA91DD04-2A82-4488-929F-8163AC5D885AQ37176377-0DEBF969-5EC8-4C7C-8FDF-14FA63A599F8Q37224386-C25AB7DC-5195-42E8-8951-7BF3E44999B0Q37385249-4F3A2FE3-8823-48DA-AE79-2D64C071ABE7Q37576974-7A061B9E-244F-423C-9FD7-720D249B86C6Q37695128-02F4008C-3D7E-4ED1-A482-5EC009F2944FQ37747013-7C89D2D3-9388-4A6D-A17C-C36D9FC54384Q38020140-E6833CBB-8F16-4389-9AAF-07708FE81808Q38071237-5603B41A-DB59-48EF-9037-4332825819EEQ38299786-45633520-5BEF-4836-9701-DC4EF16D68C6Q38306725-06812508-2AF1-402E-AB25-6C2CF2F0E40BQ38312785-C5A6BEAD-5AA7-40CD-A19A-99CFD399913AQ38342240-69FF206A-43FA-4381-8CEB-AE32F0C16A70Q38348451-B5190017-EC39-4CB7-A7ED-81C6B572FB29Q39507297-A1EA0739-E167-45C1-8F2B-3DBFBE966EB7
P2860
On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
On the mechanism for efficient ...... rt site (Inr motif) occlusion.
@ast
On the mechanism for efficient ...... rt site (Inr motif) occlusion.
@en
type
label
On the mechanism for efficient ...... rt site (Inr motif) occlusion.
@ast
On the mechanism for efficient ...... rt site (Inr motif) occlusion.
@en
prefLabel
On the mechanism for efficient ...... rt site (Inr motif) occlusion.
@ast
On the mechanism for efficient ...... rt site (Inr motif) occlusion.
@en
P2093
P2860
P356
P1476
On the mechanism for efficient ...... rt site (Inr motif) occlusion.
@en
P2093
P2860
P304
P356
10.1128/MCB.10.11.5736
P407
P577
1990-11-01T00:00:00Z